Akio Moriya

971 total citations
36 papers, 538 citations indexed

About

Akio Moriya is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Akio Moriya has authored 36 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 17 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Akio Moriya's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Akio Moriya is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Akio Moriya collaborates with scholars based in Japan, United States and Tunisia. Akio Moriya's co-authors include Kensuke Kimura, Yuko T. Hanba, Hideaki Taniguchi, Yoshiaki Iwasaki, Fusao Ikeda, Kazuhide Yamamoto, Yasushi Shiratori, Masaharu Ando, Kazuhiro Yamamoto and Yudai Iwasaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Hepatology.

In The Last Decade

Akio Moriya

34 papers receiving 528 citations

Peers

Akio Moriya
Daniel Hampton United States
Joseph T. Thompson United States
Jean Shaw United Kingdom
Akio Moriya
Citations per year, relative to Akio Moriya Akio Moriya (= 1×) peers Silvia Ferrari

Countries citing papers authored by Akio Moriya

Since Specialization
Citations

This map shows the geographic impact of Akio Moriya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akio Moriya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akio Moriya more than expected).

Fields of papers citing papers by Akio Moriya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akio Moriya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akio Moriya. The network helps show where Akio Moriya may publish in the future.

Co-authorship network of co-authors of Akio Moriya

This figure shows the co-authorship network connecting the top 25 collaborators of Akio Moriya. A scholar is included among the top collaborators of Akio Moriya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akio Moriya. Akio Moriya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumoto, Kazuyuki, Akinobu Takaki, Takuya Adachi, et al.. (2024). Anti-PD-1 Autoantibody Predicts Survival of Patients With Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab. SHILAP Revista de lepidopterología. 3(8). 1138–1147.
2.
Takeuchi, Yasuto, Kazuhiro Nouso, Shinichi Fujioka, et al.. (2023). The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab. Cancer Medicine. 12(17). 17559–17568. 3 indexed citations
3.
4.
Toyoda, Hidenori, Satoshi Yasuda, Akio Moriya, et al.. (2022). Misunderstanding of hepatitis C virus (HCV) infection status by non–specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy. Journal of Infection and Chemotherapy. 28(9). 1231–1234. 1 indexed citations
5.
Morishita, Asahiro, Kyoko Oura, Kei Takuma, et al.. (2022). Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study. Hepatology International. 17(3). 606–614. 23 indexed citations
6.
Tomonari, Tetsu, Joji Tani, Chikara Ogawa, et al.. (2022). Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma. Hepatology Research. 53(2). 172–178. 7 indexed citations
9.
Nakamura, Shinichiro, Kazuhiro Nouso, Hiroyuki Okada, et al.. (2019). Hepatocellular carcinoma recurrence in HCV patients treated with direct-acting antivirals after curative treatment. Hepatoma Research. 2019. 2 indexed citations
10.
Taniguchi, Hideaki, Yoshiaki Iwasaki, Akio Moriya, & Hiroyuki Okada. (2017). HBSAG Levels Decrease with Age in Chronic Hepatitis B: A Hospital-Based Longitudinal Study. Gastroenterology. 152(5). S1084–S1085. 1 indexed citations
11.
Moriya, Akio, et al.. (2014). Roles of alcohol consumption in fatty liver: A longitudinal study. Journal of Hepatology. 62(4). 921–927. 76 indexed citations
12.
Miyake, Yasuhiro, Kenichi Harada, Yasuni Nakanuma, et al.. (2014). Overlap of IgG4-related Sclerosing Cholangitis and Primary Biliary Cirrhosis. Internal Medicine. 53(13). 1429–1433. 3 indexed citations
13.
Kobashi, Haruhiko, Yasuhiro Miyake, Fusao Ikeda, et al.. (2011). Long‐term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine. Hepatology Research. 41(5). 405–416. 37 indexed citations
14.
15.
Moriya, Akio, Yudai Iwasaki, Hideaki Taniguchi, et al.. (2010). Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 33(3). 378–388. 88 indexed citations
16.
Maeda, Yasuhiro, et al.. (2008). Comparison of reflected green light and infrared photoplethysmography. PubMed. 2008. 2270–2272. 48 indexed citations
17.
Moriya, Akio, et al.. (2007). PROPOSAL FOR WATER-PROOF TESTING METHOD OF PLACING JOINT AND CRACKING PARTS OF CONCRETE UNDER HIGH PRESSURE. AIJ Journal of Technology and Design. 13(26). 411–414. 2 indexed citations
18.
Taniguchi, Hideaki, Yoshiaki Iwasaki, Akiko Fujiwara, et al.. (2006). Long‐term monitoring of platelet count, as a non‐invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy. Journal of Gastroenterology and Hepatology. 21(1). 281–287. 22 indexed citations
19.
Moriya, Akio, Ichinosuke Hyodo, Tomohiro Nishina, et al.. (2000). Extensive liver metastasis of gastric cancer effectively treated by hepatic arterial infusion of 5-fluorouracil/cisplatin. Gastric Cancer. 3(2). 110–115. 15 indexed citations
20.
Nakai, Toshiharu, Akio Moriya, Naoto Tonouchi, et al.. (1998). Control of expression by the cellulose synthase (bcsA) promoter region from Acetobacter xylinum BPR 2001. Gene. 213(1-2). 93–100. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026